Concepedia

Lisa Vermij

LV

Statistics

Publications

12

Citations

790

H-Index

11

Active since

2018

Affiliations

Leiden University Medical Center(Current)

Barts Health NHS Trust

Institut Gustave Roussy

Peter MacCallum Cancer Centre

Medisch Spectrum Twente

Lisa Vermij is an author at Leiden University Medical Center specializing in medicine, endometrial cancer, and oncology.

ORCID

Publications per year

2018–2024

12

Publications

12

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Lisa Vermij, Jan J. Jobsen, Alicia León‐Castillo et al. · British Journal of Cancer · 2023 · 162 citations · Full text

, , +15

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

Lisa Vermij, Alicia León‐Castillo, Naveena Singh et al. · Modern Pathology · 2022 · 161 citations · Full text

, , +17

Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

Nanda Horeweg, Hagma H. Workel, Dominik Loiero et al. · Nature Communications · 2022 · 144 citations · Full text

, , +17

Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer

Cathalijne Post, Ellen Stelloo, Vincent T.H.B.M. Smit et al. · JNCI Journal of the National Cancer Institute · 2021 · 100 citations · Full text

, , +17

HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

Lisa Vermij, Nanda Horeweg, Alicia León‐Castillo et al. · Cancers · 2020 · 98 citations · Full text

, , +14

1–5 of 12